Page last updated: 2024-09-02

kt 6149 and Breast Cancer

kt 6149 has been researched along with Breast Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arai, H; Ashizawa, T; Gomi, K; Kasai, M; Kobayashi, S; Okabe, M; Okamoto, A; Saito, H	1

Other Studies

1 other study(ies) available for kt 6149 and Breast Cancer

Article	Year
Characteristics of the antitumor activity of M-16 and M-18, major metabolites of a new mitomycin C derivative KW-2149, in mice. Anti-cancer drugs, 1995, Volume: 6, Issue:6 Topics: Animals; Antineoplastic Agents; Biotransformation; Breast Neoplasms; Cell Survival; HeLa Cells; Humans; Lethal Dose 50; Leukemia P388; Male; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Inbred Strains; Mitomycin; Mitomycins; Rats; Sarcoma 180; Tumor Cells, Cultured	1995

Article

Year

Characteristics of the antitumor activity of M-16 and M-18, major metabolites of a new mitomycin C derivative KW-2149, in mice.

Anti-cancer drugs, 1995, Volume: 6, Issue:6

Topics: Animals; Antineoplastic Agents; Biotransformation; Breast Neoplasms; Cell Survival; HeLa Cells; Humans; Lethal Dose 50; Leukemia P388; Male; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Inbred Strains; Mitomycin; Mitomycins; Rats; Sarcoma 180; Tumor Cells, Cultured

1995